- Home
- CLH vs NBIX Comparison
CLH vs NBIX Comparison
Compare CLH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLH | NBIX |
|---|---|---|
| Founded | 1980 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 14.4B |
| IPO Year | 1987 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CLH | NBIX |
|---|---|---|
| Price | $237.45 | $155.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 19 |
| Target Price | ★ $252.45 | $173.79 |
| AVG Volume (30 Days) | 622.3K | ★ 969.9K |
| Earning Date | 10-29-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.44 |
| EPS | ★ 7.20 | 4.19 |
| Revenue | ★ $5,962,257,000.00 | $2,682,700,000.00 |
| Revenue This Year | $2.95 | $23.76 |
| Revenue Next Year | $4.16 | $18.01 |
| P/E Ratio | ★ $32.97 | $37.10 |
| Revenue Growth | 2.85 | ★ 19.61 |
| 52 Week Low | $178.29 | $84.23 |
| 52 Week High | $255.44 | $157.67 |
Technical Indicators
Market Signals| Indicator | CLH | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 64.98 | 64.81 |
| Support Level | $213.85 | $150.26 |
| Resistance Level | $242.18 | $154.35 |
| Average True Range (ATR) | 6.56 | 4.16 |
| MACD | 3.53 | 1.07 |
| Stochastic Oscillator | 88.43 | 93.25 |
Price Performance
Historical ComparisonAbout CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.